Total Payments
$25,350
2024 Payments
$5,371
Companies
57
Transactions
212
Medicare Patients
7,502
Medicare Billing
$1.5M
Payment Breakdown by Category
Consulting$10,443 (41.2%)
Other$8,500 (33.5%)
Food & Beverage$5,449 (21.5%)
Travel$636.00 (2.5%)
Education$323.30 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,443 | 12 | 41.2% |
| Honoraria | $8,500 | 11 | 33.5% |
| Food and Beverage | $5,449 | 174 | 21.5% |
| Travel and Lodging | $636.00 | 2 | 2.5% |
| Education | $323.30 | 6 | 1.3% |
| Unspecified | $0 | 7 | 0.0% |
Payments by Type
General
$25,350
205 transactions
Ownership
$0
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cornerstone Specialty Network LLC | $9,722 | 20 | $0 (2024) |
| Daiichi Sankyo Inc. | $2,669 | 7 | $0 (2024) |
| BeiGene USA, Inc. | $1,925 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,816 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,683 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,563 | 10 | $0 (2024) |
| Stemline Therapeutics Inc. | $1,184 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $808.66 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $415.76 | 15 | $0 (2024) |
| COMSORT, Inc | $350.00 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,371 | 46 | BeiGene USA, Inc. ($1,925) |
| 2023 | $9,435 | 42 | Cornerstone Specialty Network LLC ($6,222) |
| 2022 | $2,960 | 16 | Cornerstone Specialty Network LLC ($2,000) |
| 2021 | $2,817 | 11 | GlaxoSmithKline, LLC. ($1,650) |
| 2020 | $494.86 | 9 | GlaxoSmithKline, LLC. ($124.73) |
| 2019 | $2,320 | 21 | Bayer HealthCare Pharmaceuticals Inc. ($1,662) |
| 2018 | $362.96 | 9 | COMSORT, Inc ($150.00) |
| 2017 | $1,589 | 58 | E.R. Squibb & Sons, L.L.C. ($422.18) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $40.62 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Oncology | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Hematology | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 09/26/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Immunology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.77 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,365.00 | General |
| 09/05/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $14.86 | General |
| 08/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Oncology | ||||||
| 07/25/2024 | Pharmacosmos Therapeutics Inc. | COSELA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: HEMATOLOGY | ||||||
| 07/18/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Oncology / Rare Diseases | ||||||
| 07/11/2024 | Azurity Pharmaceuticals, Inc. | VIVIMUSTA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 06/14/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | Genentech USA, Inc. | Columvi (Biological), Gazyva, Lunsumio | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: BioOncology | ||||||
| 05/30/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,336 | 68,389 | $1.5M | $379,899 |
| 2022 | 36 | 2,304 | 82,668 | $2.3M | $582,798 |
| 2021 | 26 | 1,561 | 41,022 | $1.1M | $308,755 |
| 2020 | 24 | 1,301 | 26,084 | $662,950 | $272,040 |
Total Patients
7,502
Total Services
218,163
Medicare Billing
$1.5M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 385 | 769 | $324,263 | $77,956 | 24.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 27 | 3,780 | $259,781 | $69,675 | 26.8% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 50 | 50,250 | $174,120 | $44,175 | 25.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 58 | 224 | $104,607 | $25,893 | 24.8% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 26 | 75 | $114,513 | $25,836 | 22.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 132 | 381 | $94,684 | $25,417 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 125 | $73,816 | $18,206 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 174 | $52,359 | $13,170 | 25.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 108 | 183 | $41,588 | $10,561 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $37,233 | $9,515 | 25.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 400 | 971 | $29,118 | $8,131 | 27.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 49 | $28,015 | $7,241 | 25.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 60 | 260 | $26,506 | $6,556 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $22,366 | $5,044 | 22.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 46 | $17,046 | $4,653 | 27.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 64 | $16,366 | $4,229 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 105 | 315 | $15,000 | $3,885 | 25.9% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 20 | 61 | $13,985 | $3,597 | 25.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 195 | 471 | $11,053 | $3,561 | 32.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 131 | 387 | $5,416 | $2,428 | 44.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $8,089 | $2,021 | 25.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 26 | 26 | $6,045 | $1,971 | 32.6% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 20 | 88 | $6,262 | $1,518 | 24.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 44 | $5,103 | $1,355 | 26.5% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 18 | 7,600 | $7,104 | $1,182 | 16.6% |
About Dr. Sameer Desai, MD
Dr. Sameer Desai, MD is a Hematology & Oncology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487776373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameer Desai, MD has received a total of $25,350 in payments from pharmaceutical and medical device companies, with $5,371 received in 2024. These payments were reported across 212 transactions from 57 companies. The most common payment nature is "Consulting Fee" ($10,443).
As a Medicare-enrolled provider, Desai has provided services to 7,502 Medicare beneficiaries, totaling 218,163 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Somerset, NJ
- Active Since 04/04/2007
- Last Updated 05/20/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1487776373
Products in Payments
- BRUKINSA (Drug) $1,925
- ZEJULA (Drug) $1,823
- Vitrakvi (Drug) $1,662
- Enhertu (Drug) $1,289
- Orserdu (Drug) $1,184
- ENHERTU (Drug) $584.31
- OPDIVO (Biological) $553.60
- KEYTRUDA (Biological) $516.17
- superDimension (Device) $256.30
- EMPLICITI (Biological) $221.35
- ERLEADA (Drug) $159.99
- Revlimid (Drug) $154.69
- XPOVIO (Drug) $137.44
- DALVANCE (Drug) $122.31
- AYVAKIT (Drug) $122.24
- Avastin (Biological) $117.00
- DARZALEX (Biological) $108.48
- clonoSEQ (Device) $104.92
- Imbruvica (Drug) $91.89
- LUMAKRAS (Drug) $90.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Somerset
Marcus Porcelli, Md, MD
Hematology & Oncology — Payments: $5,458
Hematology & Oncology $5,458
Craig Lampert, Md, MD
Hematology & Oncology — Payments: $5,451
Hematology & Oncology $5,451
Robert Fein, Md, MD
Hematology & Oncology — Payments: $4,633
Hematology & Oncology $4,633
David Richards, Md, MD
Hematology & Oncology — Payments: $3,439
Hematology & Oncology $3,439
Yumi Kim, Md, MD
Hematology & Oncology — Payments: $2,812
Hematology & Oncology $2,812
Dr. N Mullai, Md, MD
Hematology & Oncology — Payments: $175.69
Hematology & Oncology $175.69